Search Results for: "Clinic Roundup"
-
Clinic Roundup
Incyte Corp., of Wilmington, Del., reported at the European Hematology Association meeting results from two ongoing clinical trials of Jakafi (ruxolitinib), an oral JAK1 and JAK2 inhibitor that is FDA-approved for the treatment of patients with intermediate or high-risk myelofibrosis (MFBioWorld Today | Tuesday, June 18, 2013 -
Clinic Roundup
The company recently launched the Crohn's disease clinical trial and is actively recruiting participants with moderate to severe diseaseBioWorld Today | Thursday, June 13, 2013 -
Clinic Roundup
Omeros Corp., of Seattle, said it filed a clinical trial application with European regulators to initiate clinical trials of OMS721, its lead human monoclonal antibody from its mannan-binding lectin-associated serine protease-2, or MASP-2, programBioWorld Today | Wednesday, May 29, 2013 -
Clinic Roundup
The agency, however, strongly recommended that Adherex consider other larger clinical trial design alternativesBioWorld Today | Tuesday, May 28, 2013 -
Pharma: Clinic Roundup
Results of the PROLASTIN-C SPARK study, a multidose pharmacokinetic clinical trial, were presented at the annual meeting of the American Thoracic Society in PhiladelphiaBioWorld Today | Thursday, May 23, 2013 -
Clinic Roundup
The study is being sponsored by the Alliance for Clinical Trials in Oncology, a cooperative group of the National Cancer Institute (NCIBioWorld Today | Thursday, May 23, 2013 -
Clinic Roundup
Marina Biotech Inc., of Bothell, Wash., said licensee Mirna Therapeutics Inc., of Austin, Texas, has begun a Phase I study of MRX34, the first miRNA to advance into a human clinical trial for cancerBioWorld Today | Tuesday, May 21, 2013 -
Pharma: Clinic Roundup
The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), is being conducted at the NIAID Phase I Clinical Trials Unit at Case Western Reserve University in ClevelandBioWorld Today | Tuesday, May 21, 2013 -
Clinic Roundup
ACT is currently enrolling patients in three clinical trials in the U.SBioWorld Today | Friday, May 17, 2013 -
Clinic Roundup
HIV-infected subjects enrolled in an ongoing SB-728-902 clinical trial (Cohorts 1-3) received a single infusion of SB-728-T, which resulted in a durable increase in total CD4 T-cells driven by increased ZFN-modified CD4 central memory T-cellsBioWorld Today | Thursday, May 16, 2013 -
Clinic Roundup
Mirna Therapeutics Inc., of Austin, Texas, has initiated a Phase I study of MRX34, the first miRNA to advance to a clinical trial for cancerBioWorld Today | Tuesday, May 14, 2013 -
Pharma: Clinic Roundup
The study, dubbed Gammaglobulin Alzheimer's Partnership, was conducted in collaboration with the Alzheimer's Disease Cooperative Study, a clinical trial consortium supported by the National Institute on AgingBioWorld Today | Wednesday, May 8, 2013 -
Clinic Roundup
CytRx Corp., of Los Angeles, said the independent data safety monitoring committee overseeing the company's international Phase IIb trial with aldoxorubicin as a first-line treatment for patients with late-stage metastatic soft tissue sarcoma has recommended conducting the clinical trial through completion...The NH004-3 clinical trial is a double-blind, placebo-controlled, randomized, crossover, multicenter study comparing NH004 and placebo thin films in Parkinson's disease patient complaining ofBioWorld Today | Tuesday, May 7, 2013 -
Clinic Roundup
clinical trials where a single dose of NX-1207 has been found to produce on average symptomatic improvements about double that reported for currently approved BPH drugs without causing the sexual or cardiovascular side effects associated with those drugsBioWorld Today | Monday, May 6, 2013 -
Clinic Roundup
Ltd., of Germantown, Md., said it filed an investigational new drug application (IND) to begin clinical trials of its adipose-derived stem cell product, RNL-JointStem, for the treatment of osteoarthritisBioWorld Today | Friday, May 3, 2013 -
Clinic Roundup
Navidea Biopharmaceuticals Inc., of Dublin, Ohio, said the Journal of Nuclear Medicine published the results from a clinical trial of NAV4694 in healthy subjects and those with diagnosed forms of dementiaBioWorld Today | Monday, April 22, 2013 -
Clinic Roundup
clinical trials, for SMD and dry age-related macular degeneration (dry AMD...NeuroDerm Ltd., of Ness Ziona, Israel, said enrollment of patients is ongoing in its Phase IIa clinical trial of ND0612, a treatment for Parkinson's diseaseBioWorld Today | Tuesday, April 16, 2013 -
Clinic Roundup
Tengion Inc., of Winston-Salem, N.C., said the firm's clinical trial application was accepted in Sweden to start a Phase I trial testing its Neo-Kidney Augment in up to five patients with advanced chronic kidney diseaseBioWorld Today | Tuesday, April 2, 2013 -
Clinic Roundup
Cellular Biomedicine Group, of Palo Alto, Calif., launched a clinical trial for TC-DC (Tumor Stem Cell-Specific Dendritic Cell) therapy for hepatocellular carcinoma...It is the first immune cell clinical trial of its kind in ChinaBioWorld Today | Friday, March 22, 2013 -
Pharma: Clinic Roundup
Inc., of Whitehouse Station, N.J., said researchers from the Clinical Trial Service Unit at Oxford University presented results from the HPS2-THRIVE (Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events) study of Tredaptive (extended-release niacin/laropiprant) during the late-breaking clinical trial session at the American College of Cardiology 62nd Annual Scientific Session in San Francisco...Findings were presented during the late-breaking clinical trial sessionBioWorld Today | Tuesday, March 12, 2013
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.